Related Experiment Video
Updated: Jun 19, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Tuberculosis preventive treatment in eight SEAR countries - Current practices, implementation challenges and
Prathiksha Giridharan1, Rakesh P Suseela2, Tandin Zangpo3
1ICMR- National Institute for Research in Tuberculosis, Chennai, India.
Implementing Tuberculosis Preventive Therapy (TPT) in South East Asia faces challenges like low acceptance and supply chain issues. Operations research priorities include person-centered models and health system strengthening for TB elimination.
Area of Science:
- Public Health
- Infectious Disease Control
- Health Systems Research
Background:
- South East Asian countries share infectious disease control challenges with limited cross-border learning.
- The Indian Council of Medical Research (ICMR) established the RESEARCH Platform to foster health collaboration in the region.
- Tuberculosis Preventive Therapy (TPT) is crucial for TB elimination efforts.
Purpose of the Study:
- To discuss current practices, implementation challenges, and operations research priorities for TPT in eight South East Asian Region (SEAR) countries.
- To identify key areas for research and intervention to improve TPT uptake and effectiveness.
Main Methods:
- A workshop on "Capacity Building for TB Research under Programmatic Settings" was conducted.
- Data were collected using semi-structured questionnaires and open discussions during the workshop.
- Participants from eight SEAR countries contributed to the data collection and discussion.
Main Results:
- Key challenges identified include low beneficiary and provider acceptance, difficulties in ruling out active TB, and supply chain issues for diagnostics and drugs.
- Operations research priorities highlighted include person-centric TPT models, capacity building for latent TB infection care, health system strengthening, and risk communication.
Conclusions:
- Full implementation of TPT guidelines requires coordinated stakeholder action.
- Addressing identified challenges and prioritizing research are essential for maximizing TPT benefits and achieving TB elimination goals.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...